Clinical outcomes of patients with chronic pulmonary aspergillosis managed surgically

Findra Setianingrum, Riina Rautemaa-Richardson, Rajesh Shah, David W Denning

Research output: Contribution to journalArticlepeer-review

6 Downloads (Pure)

Abstract

OBJECTIVES
Surgical resection is one treatment modality for chronic pulmonary aspergillosis (CPA), and sometimes a preoperative presumption of lung cancer turns out to be CPA. We have audited our surgical experience with regard to risk factors for relapse, and the value of postoperative monitoring of Aspergillus-immunogolubulin G (IgG) titres.

METHODS
All patients with CPA surgically treated at National Aspergillosis Centre (NAC), Manchester, UK (2007–2018), were retrospectively evaluated. Surgical procedures, underlying disorders, Aspergillus-IgG titres (ImmunoCap) and antifungal therapy were evaluated for symptom control, operative complications, CPA relapse and mortality.

RESULTS
A total of 61 patients with CPA (28 males, 33 females) were operated on primarily for antifungal therapy failure (51%, n = 31) and presumed lung malignancies (38%, n = 23). Procedures included lobectomy (64%, n = 39), wedge resection (28%, n = 17), segmentectomy (n = 3), pneumonectomy (n = 3) and decortication (n = 2). Overall, 25 (41%) patients relapsed, 26 months (standard deviation: 24.8 months) after surgery. Antifungal therapy before surgery (P = 0.002) or both before and after surgery (P = 0.005) were protective for relapse. The relapse rate within 3 years after surgery (33%, n = 20) was higher than the 3–10 years after surgery (8%, n = 5). At the end of follow-up, the median Aspergillus-IgG titre was lower than at relapse in 12 patients (67 vs 126 mg/l) (P = 0.016).

CONCLUSIONS
Surgery in these selected patients with CPA resulted in favourable outcomes. Relapse is common after surgical treatment of CPA but can be minimized with antifungal therapy, emphasizing the importance of an accurate diagnosis prior to surgery.
Original languageEnglish
Number of pages7
JournalEuropean Journal of Cardio-Thoracic Surgery
Early online date9 May 2020
DOIs
Publication statusPublished - 9 May 2020

Fingerprint

Dive into the research topics of 'Clinical outcomes of patients with chronic pulmonary aspergillosis managed surgically'. Together they form a unique fingerprint.

Cite this